Tradjenta - 0597-0140-70 - (linagliptin)

Alphabetical Index


Drug Information of Tradjenta

Product NDC: 0597-0140
Proprietary Name: Tradjenta
Non Proprietary Name: linagliptin
Active Ingredient(s): 5    mg/1 & nbsp;   linagliptin
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Tradjenta

Product NDC: 0597-0140
Labeler Name: Boehringer Ingelheim Pharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA201280
Marketing Category: NDA
Start Marketing Date: 20110509

Package Information of Tradjenta

Package NDC: 0597-0140-70
Package Description: 1 BLISTER PACK in 1 CARTON (0597-0140-70) > 7 TABLET, FILM COATED in 1 BLISTER PACK

NDC Information of Tradjenta

NDC Code 0597-0140-70
Proprietary Name Tradjenta
Package Description 1 BLISTER PACK in 1 CARTON (0597-0140-70) > 7 TABLET, FILM COATED in 1 BLISTER PACK
Product NDC 0597-0140
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name linagliptin
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20110509
Marketing Category Name NDA
Labeler Name Boehringer Ingelheim Pharmaceuticals, Inc.
Substance Name LINAGLIPTIN
Strength Number 5
Strength Unit mg/1
Pharmaceutical Classes Dipeptidyl Peptidase 4 Inhibitors [MoA],Dipeptidyl Peptidase 4 Inhibitor [EPC]

Complete Information of Tradjenta


General Information